/ /

  • linkedin
  • Increase Font
  • Sharebar

    Home monitoring for AMD may have substantial impact on U.S. public health

    Use may result in hundreds of thousands of patients optimizing vision over time


    Dr. Regillo and other study investigators theorized that by using the device, patients would be able to identify the presence of choroid neovascularization (CNV) early and take advantage of appropriate treatment to arrest disease progression at an early stage when visual acuity is often good.

    Eye strokes lead to bigger risk of cardiovascular problems that previously beleived

    The importance of this early identification is underscored by the AREDS results (the AREDS 11 Report) that determined of about 8 million patients with intermediate- to high-risk AMD, about 670,000 will progress to CNV over a period of 5 years after treatment was started.

    Of those patients, about 77% may qualify to use the home monitoring device. When patient noncompliance is factored in—estimated to account for about 10% of patients—more than 400,000 patients may use home monitoring over a period of 5 years, with a resultant additional 100,000 maintaining 20/40 or better visual acuity at the time of neovascular AMD detection.

    Combined strategy

    The combination strategy of a home monitoring device and the Amsler grid—considered the standard of care—resulted in a larger proportion of study eyes with intermediate AMD maintaining vision of 20/40 or better, i.e., 87%, at diagnosis of CNV compared with study eyes evaluated with only the Amsler grid, 62%.

    Slideshow: Top 10 ophthalmic advancements over past 20 years

    These results were applied to estimates of the U.S. population at high risk of developing late AMD to estimate the potential public health effect of home monitoring with the device.

    Next: Home monitoring's impact 

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results